Advanz Seeks To Build On European Platform
Correvio And UCB Deals Position Firm For Future Growth
Advanz Pharma recently struck two major deals that have expanded its presence in Europe and bolstered its portfolio. In an exclusive interview with Generics Bulletin, CEO Graeme Duncan explains how the firm plans to build on these moves to make the most of its enhanced platform.
